307 related articles for article (PubMed ID: 27493130)
1. Challenges in pediatric drug use: A pharmacist point of view.
Balan S; Hassali MA; Mak VSL
Res Social Adm Pharm; 2017; 13(3):653-655. PubMed ID: 27493130
[TBL] [Abstract][Full Text] [Related]
2. Basics of Compounding with Dilutions and Concentrates.
Allen LV
Int J Pharm Compd; 2017; 21(1):39-45. PubMed ID: 28346197
[TBL] [Abstract][Full Text] [Related]
3. Extemporaneous drug formulations.
Nahata MC; Allen LV
Clin Ther; 2008 Nov; 30(11):2112-9. PubMed ID: 19108799
[TBL] [Abstract][Full Text] [Related]
4. Pediatric drug development: formulation considerations.
Ali AA; Charoo NA; Abdallah DB
Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
[TBL] [Abstract][Full Text] [Related]
5. Filling a niche market: administering drugs by injection or infusion.
Kaldy J
Consult Pharm; 2015 May; 30(5):256-63. PubMed ID: 25979125
[TBL] [Abstract][Full Text] [Related]
6. Basics of compounding foam dosage forms.
Allen LV
Int J Pharm Compd; 2013; 17(4):312-22. PubMed ID: 24261147
[TBL] [Abstract][Full Text] [Related]
7. Compounding in Ukraine.
Zdoryk OA; Georgiyants VA; Gryzodub OI; Schnatz R
Int J Pharm Compd; 2013; 17(2):124-7. PubMed ID: 23696172
[TBL] [Abstract][Full Text] [Related]
8. Compounding pharmacy: old methods finding a new niche.
Matheny C; Martin CM
Consult Pharm; 2010 Jun; 25(6):357-63. PubMed ID: 20534406
[TBL] [Abstract][Full Text] [Related]
9. Basics of compounding: repackaging, part 2.
Allen LV
Int J Pharm Compd; 2013; 17(2):136-40. PubMed ID: 23696175
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.
Casas M; Álvarez J; Lucero MJ
Pharm Dev Technol; 2015 May; 20(3):271-8. PubMed ID: 24279906
[TBL] [Abstract][Full Text] [Related]
11. Pediatric drug formulations: challenges and potential solutions.
Nahata MC
Ann Pharmacother; 1999 Feb; 33(2):247-9. PubMed ID: 10084423
[TBL] [Abstract][Full Text] [Related]
12. Paediatric Drug Development and Formulation Design-a European Perspective.
Van Riet-Nales DA; Kozarewicz P; Aylward B; de Vries R; Egberts TC; Rademaker CM; Schobben AF
AAPS PharmSciTech; 2017 Feb; 18(2):241-249. PubMed ID: 27270905
[TBL] [Abstract][Full Text] [Related]
13. Caring for and assessing pediatric patients: Aspects to consider as a pharmacy practitioner.
Eiland LS; Meyers RS
Am J Health Syst Pharm; 2019 Sep; 76(19):1463-1471. PubMed ID: 31532505
[TBL] [Abstract][Full Text] [Related]
14. Extemporaneous compounding activities and the associated informational needs of pharmacists.
Crawford SY; Dombrowski SR
Am J Hosp Pharm; 1991 Jun; 48(6):1205-10. PubMed ID: 1858798
[TBL] [Abstract][Full Text] [Related]
15. Optimising medication use during pregnancy: the potential role of pharmacists.
George J
Int J Pharm Pract; 2011 Apr; 19(2):81-3. PubMed ID: 21385238
[No Abstract] [Full Text] [Related]
16. Basics of compounding: Tips and hints: powders, capsules, tablets, suppositories, and sticks, part 1.
Allen LV
Int J Pharm Compd; 2014; 18(1):42-5. PubMed ID: 24881340
[TBL] [Abstract][Full Text] [Related]
17. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
Brion F; Nunn AJ; Rieutord A
Acta Paediatr; 2003 Apr; 92(4):486-90. PubMed ID: 12801118
[TBL] [Abstract][Full Text] [Related]
18. How do Japanese children take their medicines, and what are pharmacists and paediatricians doing about it?
Nakamura H; Ishikawa Y
Int J Pharm; 2014 Aug; 469(2):249-50. PubMed ID: 24704105
[TBL] [Abstract][Full Text] [Related]
19. Pediatric health care: an introduction.
Williams LA
Int J Pharm Compd; 2013; 17(1):6-8. PubMed ID: 23627241
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of container labeling in a sample of commonly prescribed children's oral medications.
Wallace LS; Keenum AJ; DeVoe JE
Res Social Adm Pharm; 2010 Dec; 6(4):272-9. PubMed ID: 21111385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
